"Testing, testing: Applied DNA Sciences' Linea COVID-19 Assay Kit can detect the mutant "UK strain," according to the FDA. By GREGORY ZELLER // JANUARY 11, 2021 Only two COVID-19 test kits earning U.S. Food and Drug Administration Emergency Use Authorization can detect the mutant “UK strain” – and one of them [...]
STONY BROOK, N.Y. – January 11, 2021 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 1,810,000 shares of common stock [...]
B.1.1.7 variant STONY BROOK, N.Y. January 8, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that the U.S. Food and Drug Administration (FDA) published a safety communication (the “Communication”) that identifies the Company’s Linea™ COVID-19 Assay Kit (the “Assay [...]
Cats are expected to be able to get the new vaccine by the fall of 2021, if approved by the USDA. In November, a Covid-19 outbreak in Denmark’s vast mink farms led to the culling of more than 17 million of the ferret-like animals to halt the spread of a new [...]
STONY BROOK, N.Y. January 5, 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that Dr. James A. Hayward, president and CEO, will participate in a fireside chat at the virtual H.C. Wainwright BIOCONNECT 2021 Conference to be held January 11-14, [...]
STONY BROOK NY. January 4. 2021. Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it expects revenues for the first fiscal quarter of 2021 ended December 31, 2020, to be in the range of $1.3 million to [...]
STONY BROOK, N.Y. December 29, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that its wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC (ADCL) has entered into a reseller and sales referral partnership with CLEARED4, a [...]
STONY BROOK, N.Y. – December 17, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the full fiscal year and quarter ended September 30, 2020. “Our activities in fiscal 2020 were principally [...]
STONY BROOK, N.Y. – December 17, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that its wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC (ADCL), has secured a safeCircle™ pooled COVID-19 surveillance testing program (the “Program”) award [...]